Cargando…

Dexamethasone misuse: Delayed viral clearance leading to severe COVID-19 pneumonia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933384/ http://dx.doi.org/10.1007/s40278-021-92039-3

Ejemplares similares

Immunosuppressants: Covid-19 pneumonia and delayed viral clearance: case report
Publicado: (2021)

Dexamethasone: COVID-19-pneumonia: case report
Publicado: (2022)

COVID-19 Pneumonia with Delayed Viral Clearance in a Patient with Active Drug-resistant Pulmonary Tuberculosis
por: Sarma, Utpal, et al.
Publicado: (2020)

Tacrolimus: Delayed clearance of COVID-19 : case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Prolongation of the coronavirus disease 2019 viral clearance time: case report
Publicado: (2021)

Bortezomib/dexamethasone: Covid-19 pneumonia: case report
Publicado: (2021)

Dexamethasone: Rebound of COVID-19-pneumonia: case report
Publicado: (2021)

Ruxolitinib: Immunosuppression leading to impaired viral RNA clearance: case report
Publicado: (2021)

Dexamethasone/temozolomide: COVID-19 and COVID-19 pneumonia: 5 case reports
Publicado: (2021)

Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load
por: Zhao, Hong, et al.
Publicado: (2022)

Colecalciferol overdose and misuse: Hypercalcaemia leading to Brugada phenocopy following drug toxicity and misuse: case report
Publicado: (2022)

Methylprednisolone/prednisolone: Delayed viral clearance and off label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine/methylprednisolone/nafamostat: Delayed viral clearance and off label use: case report
Publicado: (2021)

Risk factors for the delayed viral clearance in COVID‐19 patients
por: Chen, Xiaoping, et al.
Publicado: (2021)

Bortezomib/cyclophosphamide/dexamethasone: Reinfection in the form of COVID-19 pneumonia : case report
Publicado: (2021)

Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
por: Ji, Jingjing, et al.
Publicado: (2020)

Hydroxychloroquine/immunosuppressants: Delayed viral clearance, drug interaction and off label use: 3 case reports
Publicado: (2021)

Dexamethasone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2022)

Dexamethasone: Klebsiella pneumoniae infection: case report
Publicado: (2022)

Oxandrolone misuse: Androgenic toxicosis and aggravation of COVID-19: case report
Publicado: (2021)

Effects of dexamethasone use on viral clearance among patients with COVID-19: a multicenter cohort study
por: Lin, Shu-Min, et al.
Publicado: (2023)

Glucocorticoids: COVID-19 infection and delayed clearance of SARS-CoV-2 RNA: case report
Publicado: (2020)

Hydroxychloroquine/mycophenolate-mofetil/tacrolimus: Delayed viral clearance, gastrointestinal adverse reactions and off-label use: case report
Publicado: (2021)

Immunosuppressants: Lymphopenia, neutropenia and prolongation of the coronavirus disease 2019 (COVID-19) viral clearance: case report
Publicado: (2021)

Dexamethasone in severe COVID-19 infection: A case series
por: Hassan, Mohamed Eliwa, et al.
Publicado: (2020)

Immunosuppression in hematological cancer patients with Covid-19 —Uncomplicated infections but delayed viral clearance?
por: Boyd, Karen, et al.
Publicado: (2020)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

Betamethasone/dexamethasone/prednisone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Dexamethasone: Bordetella hinzii pneumonia and pulmonary aspergillosis: case report
Publicado: (2022)

Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
por: Sato, Shintaro, et al.
Publicado: (2021)

Severe COVID-19 Pneumonia and Delayed Bilateral Vocal Cord Paralysis
por: Torrente-Nieto, Anna, et al.
Publicado: (2023)

Antineoplastics: Prolonged viral shedding of COVID-19 pneumonia : case report
Publicado: (2021)

Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance
por: Zlei, Mihaela, et al.
Publicado: (2022)

Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis
por: Pérez-Alba, Eduardo, et al.
Publicado: (2021)

Delayed pulmonary embolism after COVID-19 pneumonia: a case report
por: Kanso, Mohamad, et al.
Publicado: (2020)

Bortezomib/dexamethasone: COVID-19 infection: case report
Publicado: (2021)

Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
por: Murayama, Yoshiaki, et al.
Publicado: (2023)

Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Jung, Jiwon, et al.
Publicado: (2020)

The combined regimens of antiviral therapy might not be useful for the viral clearance of severe COVID-19 cases
por: Li, Xuan, et al.
Publicado: (2021)

Ivermectin overdose and misuse: Acute encephalopathy due to accidental overdose following drug misuse: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4qr49u0e45nvf30g4a82j491mk